Power Law company profile

Tango Therapeutics

Biotech & Life Sciences · Boston, United States · Founded 2017 Unicorn

Biotechnology company developing novel medicines

Valuation

$2.81B

Market cap · May/2026

Revenue

$62M

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026 $1B+ revenueColt · Power Law growth-stage

Investors

6 investors on Tango Therapeutics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 1 investor entered at this stage

Third Rock Ventures

Series B+ 5 investors entered at this stage

Boxer Capital

Gilead Sciences

Cormorant Asset Management

Tavistock Group

Casdin Capital

Global footprint

Where Tango Therapeutics has talent and traffic

AI talent share

0.6% of workforce is AI talent
(1 of 154 staff)

Core AI00%

Other AI10.65%

Non-AI workforce15399.35%

Workforce by country

🇺🇸 United States · Boston HQ

Book a demo for the full country breakdown

Web traffic by country

14K monthly visits
across markets

🇺🇸 United States81.4%

🇮🇳 India10.7%

🇬🇧 United Kingdom8.6%

🇮🇱 Israel1.4%

Top 4 markets shown

Market sentiment

What the market is saying about Tango Therapeutics

An AI-synthesized read of the highest-engagement posts about Tango Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Tango Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles